Key Points
- Director Kira Scherer Wampler sold 2,000 shares on March 3 at an average price of $26 (totaling $52,000), leaving her with 19,839 shares — a 9.16% reduction in her stake — as disclosed in an SEC Form 4.
- The board authorized a $500 million share repurchase program to buy up to 8% of outstanding shares, a move that typically signals management believes the stock is undervalued.
- Doximity shares were trading down about 3.1% at $25.27 (market cap ≈ $4.67B) with a 12‑month range of $23.53–$76.51, while analysts’ average price target is $48.33 (consensus "Moderate Buy").
Doximity, Inc. (NASDAQ:DOCS - Get Free Report) Director Kira Scherer Wampler sold 2,000 shares of the firm's stock in a transaction dated Tuesday, March 3rd. The shares were sold at an average price of $26.00, for a total value of $52,000.00. Following the completion of the sale, the director owned 19,839 shares of the company's stock, valued at approximately $515,814. This represents a 9.16% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Doximity Trading Down 3.1%
Doximity stock traded down $0.80 during midday trading on Friday, reaching $25.27. The stock had a trading volume of 852,845 shares, compared to its average volume of 3,845,913. The company has a market capitalization of $4.67 billion, a P/E ratio of 25.27, a PEG ratio of 4.10 and a beta of 1.44. Doximity, Inc. has a 12 month low of $23.53 and a 12 month high of $76.51. The company has a fifty day moving average price of $34.94 and a two-hundred day moving average price of $52.04.
Doximity (NASDAQ:DOCS - Get Free Report) last issued its earnings results on Thursday, February 5th. The company reported $0.46 earnings per share for the quarter, topping analysts' consensus estimates of $0.45 by $0.01. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same quarter last year, the business earned $0.45 EPS. Doximity's revenue was up 9.8% compared to the same quarter last year. On average, equities research analysts predict that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.
Doximity declared that its board has authorized a share repurchase plan on Thursday, February 5th that allows the company to repurchase $500.00 million in outstanding shares. This repurchase authorization allows the company to repurchase up to 8% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's management believes its shares are undervalued.
Wall Street Analyst Weigh In
A number of equities research analysts recently issued reports on the company. KeyCorp set a $38.00 price objective on Doximity in a research note on Friday, February 6th. JPMorgan Chase & Co. reduced their target price on shares of Doximity from $40.00 to $33.00 and set a "neutral" rating for the company in a research note on Friday, February 20th. The Goldman Sachs Group dropped their price target on shares of Doximity from $46.00 to $34.00 and set a "neutral" rating on the stock in a research note on Friday, February 6th. Royal Bank Of Canada started coverage on shares of Doximity in a report on Thursday, January 8th. They issued an "outperform" rating and a $59.00 price objective for the company. Finally, Canaccord Genuity Group set a $34.00 price objective on shares of Doximity and gave the company a "buy" rating in a research note on Monday, February 9th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $48.33.
View Our Latest Report on DOCS
Institutional Investors Weigh In On Doximity
A number of institutional investors and hedge funds have recently made changes to their positions in DOCS. Hantz Financial Services Inc. grew its position in Doximity by 148.9% during the second quarter. Hantz Financial Services Inc. now owns 453 shares of the company's stock worth $28,000 after buying an additional 271 shares in the last quarter. Root Financial Partners LLC bought a new stake in shares of Doximity during the 3rd quarter valued at about $30,000. Whittier Trust Co. of Nevada Inc. grew its holdings in shares of Doximity by 59.5% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 480 shares of the company's stock worth $35,000 after purchasing an additional 179 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Doximity by 99.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 796 shares of the company's stock worth $35,000 after purchasing an additional 397 shares in the last quarter. Finally, Toth Financial Advisory Corp increased its position in shares of Doximity by 150.0% in the third quarter. Toth Financial Advisory Corp now owns 500 shares of the company's stock worth $37,000 after purchasing an additional 300 shares during the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.
About Doximity
(
Get Free Report)
Doximity, Inc, headquartered in San Francisco, California, operates the leading professional medical network for healthcare professionals in the United States. Founded in 2011 by Jeff Tangney and Shari Buck, the company set out to create a secure digital environment where physicians, nurse practitioners and physician assistants can collaborate, share information and stay current with clinical news. Doximity went public in June 2021 and trades on the NASDAQ under the ticker symbol “DOCS.”
The core offering of Doximity is its HIPAA-compliant communication platform, which includes a secure messaging system, digital fax services and telehealth capabilities.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
